BDSI remains committed to the chronic pain community during the COVID-19 pandemic. For more
information on access to our products, please call our customer service line at 1-800-469-0261.

Financials & Filings

Financials & Filings

Filing date Description Form Filing Group Issuer View

Statement of changes in beneficial ownership of securities

4
3,4,5
BIODELIVERY SCIENCES INTERNATIONAL INC View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
BIODELIVERY SCIENCES INTERNATIONAL INC View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
BIODELIVERY SCIENCES INTERNATIONAL INC View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
BIODELIVERY SCIENCES INTERNATIONAL INC View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
BIODELIVERY SCIENCES INTERNATIONAL INC View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
BIODELIVERY SCIENCES INTERNATIONAL INC View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
BIODELIVERY SCIENCES INTERNATIONAL INC View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
BIODELIVERY SCIENCES INTERNATIONAL INC View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
BIODELIVERY SCIENCES INTERNATIONAL INC View HTML

Quarterly report which provides a continuing view of a company's financial position

10-Q
Quarterly Filings
BIODELIVERY SCIENCES INTERNATIONAL INC View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT

Data provided by Kaleidoscope.